Cited by 242Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease

Kannel, William B.·1983·The American Journal of Cardiology

DOI 10.1016/0002-9149(83)90649-5

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0002-9149(83)90649-5

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314
Self-citation
Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project
The Pooling Project Research Group (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 994
Lipoproteins, Cardiovascular Disease, and Death
Gordon, T. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090024008 · Cited by 565

Show all 3 references

Sorted by citations

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
“gif" NDATA ITEM> ]> Introduction Epidemiological studies have demonstrated that plasma HDL-C concentration is inversely related to the incidence of coronary artery diseas”
Background
Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
Kannel, W. B. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90511-4 · Cited by 459
Self-citation
Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I. A., MacDougald, O. A., & Bommer, G. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152090 · Cited by 382
The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 377
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
“The atherogenic component of serum total-C derives from the LDL-C fraction, and the HDL-C component was shown to be inversely related to the development of CHD.39,40 Although the strength of the relation of total-C to CHD declines after 60 years of age in men, the totalC/HDL-C ratio continues to predict events reliabl…”
Background
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298
Dietary fiber and coronary heart disease
Anderson, J. W., Deakins, D. A., Floore, T. L., Smith, B. M., & Whitis, S. E. (1990) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399009527518 · Cited by 267
Framingham Study Insights into Hypertensive Risk of Cardiovascular Disease.
Kannel, W. B. (1995) · Hypertension Research · doi:10.1291/hypres.18.181 · Cited by 166
Self-citation
Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors1
Bülow, B., Hagmar, L., ESKILSSON, J., & Erfurth, E. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6346 · Cited by 144
“A low serum HDL cholesterol level seems to be a strong predictor of coronary heart disease ( 45 , 46).”
Background
Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting
Cziraky, M. J., Watson, K. E., & Talbert, R. L. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s8-a.1 · Cited by 134
Oral contraceptives, lipids and cardiovascular disease
Fotherby, K. (1985) · Contraception · doi:10.1016/0010-7824(85)90005-8 · Cited by 123
Dyslipidemia and ischemic heart disease mortality among men and women with diabetes.
Goldschmid, M. G., Barrett-Connor, E. L., Edelstein, S. L., WINGARD, D. L., Cohn, B. A., & Herman, W. H. (1994) · Circulation · doi:10.1161/01.cir.89.3.991 · Cited by 121
Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease
Gotto, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.17.2213 · Cited by 113
Cardiovascular disease, inflammation, and periodontal infection
Paquette, D. W., Brodala, N., & Nichols, T. C. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00196.x · Cited by 110
“For example, the Framingham Heart Study (n 1⁄4 32,995) showed that for various cholesterol levels between 185 and 335 mg/dl, cardiovascular risk was elevated with the addition of each of the following risk factors: glucose intolerance, elevated systolic blood pressure, cigarette smoking, and left ventricular hypertrop…”
Background
Comparative effects of lipid-lowering therapies
Davidson, M. H., & Toth, P. P. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.007 · Cited by 106
Current and Future Directions of Cardiovascular Risk Prediction
Smith, S. C. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.013 · Cited by 96
Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study
Bhalodkar, N. C., Blum, S., Rana, T., Bhalodkar, A., Kitchappa, R., Kim, K.-S., & Enas, E. A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.040 · Cited by 92
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
van Leuven, S. I., Hezemans, R., Levels, J. H. M., Snoek, S., Stokkers, P. C. F., Hovingh, G. K., Kastelein, J. J. P., Stroes, E. S. G., de Groot, E., & Hommes, D. W. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700176-jlr200 · Cited by 89
“Interestingly, HDL from patients with active CD, without CVD, was characterized by a higher anti-oxidative score compared with healthy volunteers, indicating an attenuated antiatherogenic potential 2644 Journal of Lipid Research Volume 48, 2007 (45).”
BackgroundInfluential
HDL and type 2 diabetes: the chicken or the egg?
Xepapadaki, E., Nikdima, I., Sagiadinou, E. C., Zvintzou, E., & Kypreos, K. E. (2021) · Diabetologia · doi:10.1007/s00125-021-05509-0 · Cited by 89
Isolation and Partial Characterization of the Inactive and Active Forms of Human Plasma Phospholipid Transfer Protein (PLTP)
Kärkkäinen, M., Oka, T., Olkkonen, V. M., Metso, J., Hattori, H., Jauhiainen, M., & Ehnholm, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112247200 · Cited by 87
Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma.
Osono, Y., Woollett, L. A., Marotti, K. R., Melchior, G. W., & Dietschy, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4114 · Cited by 83
Long-term Plasma Lipid Changes Associated with a First Birth: The Coronary Artery Risk Development in Young Adults Study
Gunderson, E. P. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh146 · Cited by 79
High Density Lipoproteins in Health and in Disease
Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80
Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.
Muuronen, A., Kaste, M., Nikkilä, E., & Tolppanen, E. ‐. (1985) · BMJ · doi:10.1136/bmj.291.6507.1481 · Cited by 79
Cardiac Disease in Chronic Uremia: Clinical Outcome and Risk Factors
Foley, R. N., & Parfrey, P. S. (1997) · Advances in Renal Replacement Therapy · doi:10.1016/s1073-4449(97)70032-3 · Cited by 77
GENDER, LIPOPROTEINS, DIET, AND CARDIOVASCULAR RISK
Crouse, J. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91320-2 · Cited by 75
Disturbances of insulin in British Asian and white men surviving myocardial infarction.
Hughes, L. O., Cruickshank, J. K., Wright, J., & Raftery, E. B. (1989) · BMJ · doi:10.1136/bmj.299.6698.537 · Cited by 72
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
Nelson, A. J., Sniderman, A. D., Ditmarsch, M., Dicklin, M. R., Nicholls, S. J., Davidson, M. H., & Kastelein, J. J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169417 · Cited by 72
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Kastelein, J. J. P., Hsieh, A., Dicklin, M. R., Ditmarsch, M., & Davidson, M. H. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01184-1 · Cited by 69
“Epidemiological studies have shown that LDL-C is directly and HDL-C is inversely associated with the risk of atherosclerotic cardiovascular disease (ASCVD) [6–10].”
Background
41‐Month Follow‐Up of Risk Factors Correlated With New Coronary Events in 708 Elderly Patients
Aronow, W. S., Herzig, A. H., Etienne, F., D'Alba, P., & Ronquillo, J. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb05679.x · Cited by 68
Celiprolol
Milne, R. J., & Buckley, M. M.-T. (1991) · Drugs · doi:10.2165/00003495-199141060-00009 · Cited by 67
Risk Factors and the Sex Differential in Coronary Artery Disease
Price, J. F., & Fowkes, F. G. R. (1997) · Epidemiology · doi:10.1097/00001648-199709000-00018 · Cited by 66
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
Kapur, N. K. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.39 · Cited by 72
PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma
Siggins, S., Jauhiainen, M., Olkkonen, V. M., Tenhunen, J., & Ehnholm, C. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300059-jlr200 · Cited by 64
Nutrition and the Occurrence and Prevention of Cardiovascular Disease in the Elderly
Kannel, W. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1988.tb05389.x · Cited by 63
Self-citation
Screening Asymptomatic Adults for Cardiac Risk Factors: The Serum Cholesterol Level
Garber, A. M., Sox, H. C., & Littenberg, B. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-8-622 · Cited by 63
Lipids and lipoproteins as predictors of coronary heart disease, stroke, and cancer in the honolulu heart program
REED, D. M., Yano, K., & Kagan, A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90631-5 · Cited by 62
Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women
Hong, M. K., Romm, P. A., Reagan, K., Green, C. E., & Rackley, C. E. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90323-d · Cited by 61
Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
Tulenko, T. N., Laury‐Kleintop, L. D., Walter, M. F., & Mason, R. P. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00242-8 · Cited by 60
Alterations in lipid and protein profiles of plasma lipoproteins in middle-aged men consequent to an aerobic exercise program
Baker, T. T., Allen, D., Lei, K. Y., & Willcox, K. K. (1986) · Metabolism · doi:10.1016/0026-0495(86)90040-5 · Cited by 58
Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin
Arca, M. (1994) · JAMA · doi:10.1001/jama.271.6.453 · Cited by 59
Some pharmacological effects of the ethanol extract of leaves ofAnnona diversifolia on the central nervous system in mice
González-Trujano, M. E., Navarrete, A., Reyes, B., & Hong, E. (1998) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199812)12:8 · Cited by 49
Hypolipidaemic effect of fenugreek seeds. A clinical study
Sharma, R. D., Raghuram, T. C., & Rao, V. D. (1991) · Phytotherapy Research · doi:10.1002/ptr.2650050313 · Cited by 54
Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype
Taylor, J. M. W., Allen, A.-M., & Graham, A. (2014) · Clinical Science · doi:10.1042/cs20140047 · Cited by 56
Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels
Brewer, H. B. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-620990-7.50018-8 · Cited by 53
Failure of 40 Weeks of Brisk Walking to Alter Blood Lipids in Normolipemic Women
Santiago, M. C., Leon, A. S., & SERFASS, R. C. (1995) · Canadian Journal of Applied Physiology · doi:10.1139/h95-033 · Cited by 49
Cardiovascular Disease Risk Assessment and Prevention
Alagona, P., & Ahmad, T. A. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.02.003 · Cited by 47
Vitamin D Deficiency Prevalence and Predictors in Early Pregnancy among Arab Women
Al-Musharaf, S., Fouda, M. A., Turkestani, I. Z., Al-Ajlan, A., Sabico, S., Alnaami, A. M., Wani, K., Hussain, S. D., Alraqebah, B. A., Al-Serehi, A., et al. (2018) · Nutrients · doi:10.3390/nu10040489 · Cited by 47
Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
Shepherd, J. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.06.004 · Cited by 46
Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: Have they been adequately evaluated?
Fetters, J. K., Peterson, E. D., Shaw, L. J., Newby, L. K., & Califf, R. M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90289-6 · Cited by 44
Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes
Welty, F. K., Lichtenstein, A. H., Barrett, P. H. R., Dolnikowski, G. G., & Schaefer, E. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137975.14996.df · Cited by 43
Management of Lipids in Primary and Secondary Prevention of Cardiovascular Diseases
Lavie, C. J., Gau, G. T., Squires, R. W., & Kottke, B. A. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64891-5 · Cited by 43
The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease
Windler, E. E. T., Schoeffauer, M., & Zyriax, B. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.032 · Cited by 43
“4 mmol/L (55 mg/dL) in women (figure 2).(24) In line with this and other observational cohort studies, the Göttingen Risk, Incidence and Prevalence Study (GRIPS) showed that the risk for myocardial infarction (MI) was increased at least five-fold among those subjects with moderately elevated LDL-cholesterol concentrat…”
BackgroundResult
Comparison of two triphasic contraceptives with different progestogens: Effects on metabolism and coagulation proteins
Ball, M. J., Ashwell, E., Jackson, M., & Gillmer, M. D. G. (1990) · Contraception · doi:10.1016/0010-7824(90)90036-u · Cited by 42
Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample
Jänis, M. T., Siggins, S., Tahvanainen, E., Vikstedt, R., Silander, K., Metso, J., Aromaa, A., Taskinen, M., Olkkonen, V. M., Jauhiainen, M., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400250-jlr200 · Cited by 41
“heart disease (1, 2), primarily by removing cholesterol”
Background
Apolipoprotein E activates the low-activity form of human phospholipid transfer protein
Jänis, M. T., Metso, J., Lankinen, H., Strandin, T. M., Olkkonen, V. M., Rye, K., Jauhiainen, M., & Ehnholm, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.164 · Cited by 40
Progestagen-only oral contraceptives: Comparison of the metabolic effects of levonorgestrel and norethisterone
Ball, M., Ashwell, E., & Gillmer, M. D. G. (1991) · Contraception · doi:10.1016/0010-7824(91)90014-7 · Cited by 40
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women
Hirvonen, E., LIPASTI, A., Mälkönen, M., Kärkkäinen, J., Nuntila, J., Timonen, H., & Manninen, V. (1987) · Maturitas · doi:10.1016/0378-5122(87)90054-5 · Cited by 39
Women and Men with Hypercholesterolemia Respond Similarly to an American Heart Association Step 1 Diet
Geil, P., Anderson, J. W., & Gustafson, N. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00118-2 · Cited by 38
A multidimensional assessment of nutritional and health status of rural elderly Malays.
Shahar, S., Ibrahim, Z., Fatah, A. R. A., Rahman, S. A., Yusoff, N. A. M., Arshad, F., Yassin, Z., & Adznam, S. N. (2007) · PubMed · Cited by 36
Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging
Phan, B. A. P., Chu, B., Polissar, N. L., Hatsukami, T. S., Yuan, C., & Zhao, X.-Q. (2006) · International journal of cardiac imaging · doi:10.1007/s10554-006-9175-7 · Cited by 36
“[11, 18] Previous imaging studies [19, 20] of”
5 alpha-Cholest-8(14)-en-3 beta-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content.
Schroepfer, G. J., Sherrill, B. C., Wang, K. S., Wilson, W. K., Kisić, A., & Clarkson, T. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6861 · Cited by 36
Lipids and hypertension: Implications of new guidelines for cholesterol management in the treatment of hypertension
Grimm, R. H., & Hunninghake, D. B. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90161-0 · Cited by 35
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
Murakami, H., Tanabe, J., Tamasawa, N., Matsumura, K., Yamashita, M., Matsuki, K., Murakami, H., Matsui, J., & Suda, T. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.022 · Cited by 35
“level and the prevalence of cardiovascular disease [1,2,19,20].”
Background
Diet and plasma lipids in women. II. Macronutrients and plasma triglycerides, high-density lipoprotein, and the ratio of total to high-density lipoprotein cholesterol in women: The Framingham Nutrition Studies
Sonnenberg, L. M., Quatromoni, P. A., GAGNON, D. R., Cupples, L. A., FRANZ, M. M., Ordovás, J. M., Wilson, P. W. F., Schaefer, E. J., & Milien, B. E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00031-5 · Cited by 33
High density lipoprotein and coronary heart disease.
Betteridge, D. J. (1989) · BMJ · doi:10.1136/bmj.298.6679.974 · Cited by 32
Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages
Allen, A. M., & Graham, A. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-169 · Cited by 31
“Regression and stabilisation of atherosclerotic lesions requires the efficient removal of cholesterol from macrophage ‘foam cells’ to apolipoprotein (apo)A-I or apoE, allowing nascent high density lipoprotein (HDL) particles to enter and mature within the reverse cholesterol transport (RCT) pathway in the bloodstream,…”
Background
Lipids, lipoproteins and coronary heart disease in minority populations
Harris‐Hooker, S., & Sanford, G. L. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90155-4 · Cited by 29
The Tromsø Heart Study
Knutsen, S. F., & Knutsen, R. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700116 · Cited by 28
Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g)
Al‐Rasadi, K., Awan, Z. A., Al-Waili, K., Ruel, I. L., Hafiane, A., Krimbou, L., & Genest, J. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.010 · Cited by 28
Obesity and nutrition in elderly diabetic patients
Kannel, W. B., Garrison, R. J., & Wilson, P. W. F. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90534-6 · Cited by 28
Self-citation
Time to first cigarette and serum cholesterol levels
Selya, A., & Hesse, N. D. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.12.014 · Cited by 27
“…even protective) (NIH Medline Plus, 2012); LDL was coded as <130 mg/dL (optimal or near optimal) vs. ≥130 mg/dL (borderline high, high, and very high) (NIH Medline Plus, 2012); and the LDL/HDL ratio was coded as <3.5 (optimal) vs. ≥3.5 (sub-optimal) (American Heart Association, 2016; Kannel, 1983).”
BackgroundInfluential
The smooth muscle cell membrane during atherogenesis: A potential target for amlodipine in atheroprotection
Tulenko, T. N., Sumner, A. E., Chen, M., Huang, Y., Laury‐Kleintop, L. D., & Ferdinand, F. D. (2001) · American Heart Journal · doi:10.1067/mhj.2001.109947 · Cited by 27
Characterization and identification of women with angina pectoris
Holdright, D. R., & Fox, K. M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014902 · Cited by 26
Fitness in the fit: does physical conditioning affect cardiovascular risk factors in middle-aged marathon runners?
Ketelhut, R. G., Ketelhut, K., Messerli, F. H., & Badtke, G. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014835 · Cited by 25
Computed tomography-measured trunk fat and plasma lipoprotein levels in nonobese women
Pouliot, M., Després, J., Moorjani, S., Tremblay, A., Lupien, P. J., Nadeau, A., Thériault, G., & Bouchard, C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90166-2 · Cited by 25
Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects
Tasaki, H., Nakashima, Y., Nandate, H., Yashiro, A., Kawashima, T., & Kuroiwa, A. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90004-0 · Cited by 25
Incremento de las HDL como arma terapéutica en la aterotrombosis
Badimón, J. J., & Ibáñez, B. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70091-9 · Cited by 25
Lipid disorders in hospital attendants in Kumasi, Ghana.
Micah, F. B., & Nkum, B. C. (2012) · Europe PMC (PubMed Central) · Cited by 24
Blood Lipid Effects of Antihypertensive Therapy: A Double‐Blind Comparison of the Effects of Methyldopa and Propranolol
Leon, A. S., Agre, J. C., McNally, C., Bell, C., NEIBLING, M., Grimm, R. H., & Hunninghake, D. B. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb02776.x · Cited by 24
Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease
Sprecher, D. L., Watkins, T. R., Behar, S., Brown, W. V., Bloomfield, H. E., & Schaefer, E. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03309-x · Cited by 23
Costs and Effectiveness of Cholesterol Screening in the Elderly
Garber, A. M., Littenberg, B., Sox, H. C., Gluck, M. E., Wagner, J. L., & Duffy, B. M. (1989) · University of Michigan Library Repository · Cited by 24
Trends in blood pressure, lipids, lipoproteins and glucose metabolism in the Northern Sweden MONICA project 1986 - 99
Jansson, J., Boman, K., & Messner, T. (2003) · Scandinavian Journal of Public Health · doi:10.1080/14034950310001397 · Cited by 22
“High levels of high-density lipoprotein (HDL) cholesterol, on the other hand, have been suggested to protect against atherosclerotic manifestations ( 5 ).”
Background
Strength Training and Lipoprotein-Lipid Profiles
Kokkinos, P. F., & Hurley, B. F. (1990) · Sports Medicine · doi:10.2165/00007256-199009050-00002 · Cited by 22
Topical timolol and serum lipoproteins.
West, J., & Longstaff, S. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.11.663 · Cited by 21
Lipid and Lipoprotein Abnormalities in Young Quadriplegic Men
Shetty, K. R., Sutton, C. H., Rudman, I. W., & Rudman, D. R. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199204000-00001 · Cited by 20
Effect of depot medroxyprogesteroneacetate and testosteroneoenanthate on serum lipoproteins in man
Wallace, E. M., & Wu, F. C. W. (1990) · Contraception · doi:10.1016/0010-7824(90)90127-h · Cited by 20
Does pregnancy alter life-course lipid trajectories? Evidence from the HUNT Study in Norway
Markovitz, A. R., Haug, E. B., Horn, J., Fraser, A., Macdonald-Wallis, C. M., Tilling, K. M., Rimm, E. B., Missmer, S. A., Williams, P. L., Romundstad, P., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p085720 · Cited by 20
“risk (62, 63), recent findings suggest that raising HDL-C”
Background
Wine and Health: Evidence and Mechanisms
Urquiaga, I., & Leighton, F. (2005) · KARGER eBooks · doi:10.1159/000088299 · Cited by 19
Regular Non-Vigorous Physical Activity and Cholesterol Levels in the Elderly
Knight, S., Bermingham, M., & Mahajan, D. (1999) · Gerontology · doi:10.1159/000022090 · Cited by 19
Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants
Tada, H., Kawashiri, M., & Yamagishi, M. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2016.159 · Cited by 17
Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
Chang, C.-T., Yang, C., Tsai, F., Lin, S.-Y., & Chen, C. (2015) · BioMed Research International · doi:10.1155/2015/164846 · Cited by 18
“SerumHDL level is thought to be inversely related with atherosclerotic vascular disease (ASVD) risk [2, 3].”
Background
6 Hyperlipidaemia and hypertension
Krone, W., & Müller‐Wieland, D. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80081-3 · Cited by 18
Plasma lipid, lipoprotein and apolipoprotein profiles in Nigerian university athletes and non-athletes.
Oyelola, O. O., & Rufai, M. A. (1993) · British Journal of Sports Medicine · doi:10.1136/bjsm.27.4.271 · Cited by 18
Blood Pressure, Metabolic Variables and Adipose Tissue Distribution in Pre‐And Post‐Menopausal Women
Armellini, F., Micciolo, R., Ferrari, P., Zamboni, M. M., Gottardi, L., Cavallo, E., & Bosello, O. (1990) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349009028708 · Cited by 18
Mixed dyslipidemias in primary care patients in France
Ambegaonkar, B. M., LaForest, Souchet, Sazonov, & Ganse, E. H. V. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s27668 · Cited by 16
“Except for Framingham risk score and history of CVD/ CHD, cardiovascular risk factors tended to be significantly associated either with attainment of normal levels for HDL-C and/or triglycerides but not LDL-C goal, or vice versa.”
Influential
Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene
Tada, H., Kawashiri, M., Nohara, A., Saito, R., Tanaka, Y., Nomura, A., Konno, T., Sakata, K., Fujino, N., Takamura, T., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.003 · Cited by 17
Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy
Charland, S. L., & Malone, D. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903484802 · Cited by 18
Association of Lifestyle with Serum Lipid Levels: a Study of Middle-Aged Japanese Men.
Nakanishi, N., Tatara, K., Nakamura, K., & SUZUKI, K. S. (2000) · Journal of Epidemiology · doi:10.2188/jea.10.216 · Cited by 17
Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells
Siripurkpong, P., & Na‐Bangchang, K. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.02.010 · Cited by 17

Authors: Kannel, W. B.
Affiliations: Boston University (US)
Corresponding author: Kannel, William B.
Venue: The American Journal of Cardiology
Publisher: Elsevier BV
Published: 1983-08
Volume: 52
Issue: 4
Pages: B9-B12
ISSN: 0002-9149 (ISSN-L)
DOI: 10.1016/0002-9149(83)90649-5
OpenAlex: W2084240983
Cited by: 242
References: 3
Citations by year: 2026: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 12
FWCI: 8.67
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The American Journal of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, HDL cholesterol, coronary artery disease, LDL cholesterol, LDL/HDL ratio, total cholesterol, atherogenesis, lipoprotein subfractions, apolipoproteins, stroke, peripheral arterial disease, colon cancer, cardiovascular risk
MeSH terms: Cholesterol, Coronary Disease, Humans, Lipoproteins, HDL, Cholesterol, HDL, Lipoproteins, LDL, Cholesterol, LDL, Lipoproteins, VLDL, Risk, Triglycerides, Cholesterol, VLDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks